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INTRODUCTION 
Bovine herpesvirus-1 (BHV-1) is responsible for a variety of 
disease conditions in cattle. Included among these are rhinotracheitis, 
conjunctivitis, vulvovaginitis, balanoposthitis, meningoencephalitis, 
and fatal systemic infection (45,70). 
A significant aspect of infection with BHV-1 is the ability of the 
virus to persist beyond the acute infection in inoculated animals. As 
early as 1910, epidemiological evidence suggested that BHV-1 might 
persist in infected cattle (107). Since then a large body of literature 
has confirmed this early suggestion and provided a basic, although not 
complete, understanding of persistent BHV-1 infection. 
Bovine herpesvirus-1 establishes a persistent infection in most, 
if not all, experimentally infected cattle. Sheffy and Davies (105) 
found that 100% of 18 previously infected animals were persistently 
infected. Straub (3.14) and Davies and Duncan (22) also found 100% rates 
of persistent infection in previously infected cattle. 
Intermittent shed of BHV-1 is characteristically seen in persistently 
infected cattle. On two occasions, McKercher et al. (65) isolated BHV-1 
from nasal secretions of cattle 2-3 months after experimental inoculation. 
Snowdon (107) found that BHV-1 could be recovered intermittently from 
infected cattle over a period of 578 days. Multiple incidents of 
spontaneous virus shed also were observed in two BHV-1 infected bulls 
over a period of approximately two years (9). Recurrent virus shed and 
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disease have been induced in persistently infected cattle following 
various experimental treatments. Sheffy and Davies (105) and Davies and 
Duncan (22) used dexamethasone, a synthetic corticosteroid, to induce 
recurrent virus shed and disease in persistently infected cattle. Davies 
and Carmichael (21) found that adrenocorticotropic hormone and trigeminal 
neurotomy were both sufficient treatments for the activation and shed 
of BHV-1 from persistently infected cattle. Superinfection with para-
influenza-3 virus also has been shown capable of inducing recurrent 
BHV-1 infection in persistently infected calves (67). 
Like other members of the alpha herpesvirus group, BHV-1 is thought 
to persist in sensory and autonomic nerve ganglia, and to travel centrif-
ugally via nerves to produce recurrent virus shed and disease (40,75j 
78,79). Bovine herpesvirus-1 specific fluorescence was detected in the 
trigeminal ganglia of dexamethasone treated persistently infected calves 
prior to the appearance of virus in the nasal mucosa (78). Bovine 
herpesvirus-1 also has been isolated from the trigeminal ganglia of 
clinically normal cattle at slaughter (40), although prior attempts 
by other researchers to isolate virus from ganglia of non-dexamethasone 
treated experimentally infected cattle were unsuccessful (21,22). 
Recently, Horaan and Easterday (41) have demonstrated the presence of 
BHV-1 DNA in neurons of the trigeminal and superior cervical ganglia 
of persistently infected calves. 
Many unanswered questions regarding BHV-1 persistence remain. 
Little is known about the virus-cell-host interaction that is responsible 
for initiation, maintenance, and reactivation of persistent infection. 
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In addition, it is not known if the natural course of persistent BHV-1 
infection can be modulated. More specifically, can Immunologic or 
physiologic manipulations prevent the establishment of persistent 
infections in non-infected animals, or prevent the reactivation and shed 
of virus in animals already persistently infected? The development of a 
laboratory model of persistent BHV-1 Infection may facilitate the study 
of these and other questions pertaining to persistent BHV-1 infection. 
Rabbits have been Infected experimentally with BHV-1 and suggested 
as possible laboratory models for studying the pathogenesis of BHV-1 
infection (46,59,60). Lupton et al. (60) have isolated BHV-1 from the 
trigeminal and optic nerves of rabbits during acute conjunctival infection 
and have suggested that the potential exists for the establishment of 
persistent infection. 
The objectives of this research were to determine if persistent 
infections could be established in BHV-1 infected rabbits and to evaluate 
the rabbit as a laboratory model of persistent BHV-1 infection. 
Explanation of Dissertation Format 
This dissertation consists of an introduction, a literature review, 
two separate manuscripts, a general conclusion, references and acknowl­
edgements. The Ph.D. candidate, Daniel Leo Rock is the senior author 
and principal investigator for each of the manuscripts. 
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LITERATURE REVIEW 
Persistent Bovine Herpesvirus-1 Infection 
A characteristic of all herpesviruses is the ability to establish 
persistent infection (109). It has been shown that BHV-1 establishes 
a persistent infection in virtually all cattle following inoculation by 
the vaginal (22,42,107), preputial (9), intravenous (107), or intranasal 
route (22,105). Persistent BHV-1 infection has been characterized by the 
following: (1) Persistently infected animals have been reported to shed 
virus intermittently without evidence of clinical disease (9,42,107), and 
(2) Virus has been reactivated predictably from persistently infected 
cattle following various experimental treatments (22,67,105). 
Spontaneous reactivation of persistent infection 
Bovine herpesvirus-1 has been recovered intermittently from cattle 
which had been Inoculated previously by the vaginal (22,42,107), preputial 
(9,52,115), intravenous (107), or intranasal route (65). In all of the 
above reports, recurrent virus shed was detected without the appearance 
of clinical disease. McKercher et al. (65) isolated virus from nasal 
washings of animals 2-3 months post-infection. Studdert et al. (115) 
detected virus in preputial washings of a bull 26 days post-infection, 
although washings taken at 12, 16, and 19 days post-infection failed to 
yield virus. Kubin (52) also reported the isolation of BHV-1 from preputial 
washings taken from a clinically normal bull. Snowdon (107) detected 
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7 separate periods of virus shed over a period of 578 days in an intra­
venously inoculated animal. In addition, six periods of virus shed were 
detected in a bull under observation for 1 year. On 17 different occasions, 
over a period of two years, Bitsch (9) isolated BHV-1 from preputial 
washings taken from two persistently infected bulls. The titer of virus 
recovered in the washings ranged from 10^ - 10^ TCID^Q's per ml of wash 
and was lower than the amount of virus seen during the acute infection 
or following prednisolone injections. Huck et al. (42) observed that inter­
mittent virus shed from persistently infected heifers was more frequent 
during the first 5 months of a 12 month observation period. Incidents 
of spontaneous virus shed in the heifers ranged from 1 to 6 days. 
Intermittent virus shed has been shown to occur at the original site 
of inoculation. Bovine herpesvirus-1 was recovered from vaginal but 
not nasal swabs taken from animals initially infected by the vaginal route 
(35,42,107). Snowdon (107) detected intermittent BHV-1 shed from both 
the nose and the vagina of an animal that had been infected by the 
intravenous route. 
Fluctuations of serum neutralizing antibody titer in individual 
persistently infected animals have been reported by several researchers 
(9,42,107). Attempts to correlate recurrent virus shed with the presence 
or absence of serum neutralizing antibody have proven unsuccessful (9,42). 
Snowdon (107) found that rises in titer followed a period of recurrent 
virus shed. However, Bitsch (9) found little to no rise in serum 
neutralizing antibody following periods of virus shed. 
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Induced reactivation of persistent infection 
A variety of experimental treatments has been used in an attempt 
to induce recurrent BHV-1 infection in persistently infected cattle. 
One such treatment, corticosteroid treatment, has been shown to induce 
BHV-1 recurrence (2,9,21,22,24,25,33,44,52,78,79,81,88,105,114). Studies 
on experimentally infected cattle have demonstrated virus shed in virtually 
all animals following corticosteroid treatment (9,21,22,105,114). Corti­
costeroid treatment of naturally infected cattle has resulted in re­
currence of infection in 60-100% of the animals treated (24,25,52). 
A number of observations have been made on cattle following an initial 
corticosteroid induced viral recurrence. Davies and Duncan (22) reported 
that clinical signs of infection were first seen 3 to 4 days after initi­
ation of dexamethasone treatment. Recurrent virus shed was first detected 
2 to 4 days post-treatment initiation and persisted for 4-7 days. Similar 
observations have been made by others (9,21,22,25,44,78,79,80,105). 
An increase in the anti-BHV-1 serum neutralizing antibody titers of per­
sistently infected animals characteristically was seen following corti­
costeroid Induced recurrence of disease (9,21,44,88,89). However, 
Dennett et al. (25) and Darcel and Dorward (20) found no significant 
changes in levels of serum antibody following dexamethasone treatment. 
Variations of the observations described above were seen in subsequent 
corticosteroid induced reactivations attempted on the same animal. 
Davies and Duncan (22) found a variable pattern of virus excretion when 
persistently Infected animals were re-treated with dexamethasone 4 weeks 
after the initial treatment. Virus was recovered later and shed for a 
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shorter period of time following the second treatment. A more typical 
response was seen when animals received their second treatment 3 months 
after the initial one, although variable patterns of virus excretion 
still were observed in some animals. Similar results have been obtained 
by others (88,89,114). 
Davies and Carmichael (21) and Davies and Duncan (22) induced 
BHV-1 recurrence using adrenocorticotrophic hormone (ACTH). The 
effectiveness of this treatment was due to increased endogenous corti­
costeroid release. The recurrent infection observed following ACTH 
treatment was similar to that seen following corticosteroid treatment. 
Trigeminal neurotomy has been suggested as a sufficient condition 
for reactivation of BHV-1 (21) . Virus was recovered from the denervated 
nostril in 1 of 2 treated calves 11 days post-surgery. 
Reactivation of persistently infected calves after experimental 
infection with parainfluenza-3 virus (PI-3) has been described by Mensik 
et al. (67). It was suggested that PI-3 virus acted like other non­
specific stressing factors in causing recurrent BHV-1 infection. 
Snowdon (107) has recovered BHV-1 from a persistently infected cow 
following each of two sequential calvings. Clinically apparent infection 
was seen 5 days after the birth of the first calf, but was absent following 
the second birth. 
The immune response and persistent infection 
Vaccination of cattle with an inactivated or a modified live BHV-1 
vaccine was unable to prevent the establishment of a persistent infection 
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following a subsequent infection with virulent virus (80,106). 
Although vaccination failed to prevent latent infection, a variety 
of reports suggested a role for the immune response in altering the 
natural course of recurrent BHV-1 infection. Davies and Carmichael (21) 
observed that the cellular immune response of dexamethasone treated 
persistently infected cattle was depressed at the time of virus reacti­
vation. They suggested that the observed defect in cellular immunity was 
not responsible for viral reactivation, but would account for the apparently 
unrestricted multiplication of the virus and the development of clinically 
apparent disease seen in dexamethasone induced recurrent infection. 
Pastoret et al. (89) have shown enhanced BHV-1 specific lymphocyte 
blastogenesis, antibody dependent cellular cytotoxicity, and serum 
neutralizing antibody titers in cattle following dexamethasone induced 
viral recurrence. The authors have suggested that this enhanced level 
of immunity was responsible for the reduction in the amount and duration 
of virus excretion observed in the cattle following a second dexamethasone 
treatment. Enhanced immunity has also been suggested in explaining the 
variable virus excretion patterns observed in persistently infected 
cattle following multiple corticosteroid treatments (22,88). 
Some reports have indicated that hyperimmune persistently infected 
cattle failed to excrete BHV-1 following corticosteroid treatment. 
Kokles (49) observed that cattle immunized with a BHV-1 live virus vaccine 
and subsequently infected with virulent field virus could not be reactivated 
using corticosteroids. In a similar experiment, Pastoret et al. (89) 
10 
were unable to induce recurrent BHV-1 shed in cattle that had been 
vaccinated with a temperature sensitive BHV-1 vaccine and challenged with 
a virulent virus. In contrast, Straub (114) found that cattle infected 
with field virus, and subsequently vaccinated, could be reactivated 
using corticosteroid treatment. In addition, Dennett et al. (25) found 
no correlation between the initial serum neutralizing antibody titer of 
naturally infected cattle and the ability to induce BHV-1 recurrence in 
them. Clarification of this important question will require further 
study. 
The Pathogenesis of Persistent Bovine Herpesvirus-1 Infection 
Acute phase of infection 
Experimental infection of cattle with bovine herpesvirus-1 by the 
nasal (4,22,28,34,65,75), conjunctival (77), vaginal (22,76), and 
preputial route (115) has resulted in localization and replication of virus 
at the site of inoculation and generalization of the infection to distant, 
non-inoculated areas. Neural spread, hematogenous spread, lymphatic 
drainage, and extension of virus infection by multiplication from a 
primary to a secondary site have been suggested as mechanisms for 
generalization of BHV-1 infection (4,22,34,65,75,76,85). 
Davis and Duncan (22) observed that intranasal infection of cattle 
with BHV-1 resulted in inflammation of the nasal and conjunctival epithelium, 
trigeminal ganglionitis, and mild inflammation of the medulla oblongata 
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and pons. Virus was isolated from the nasal mucosa, conjunctival 
mucosa, trigeminal nerve, trigeminal ganglia, medulla oblongata, pons, 
cerebrum, olfactory bulb, adrenal gland, and tissues of the genital 
tract. Narita et al. (75) using the Los Angeles strain of BHV-1 
obtained similar histopathologic results, although more severe lesions 
were observed in the medulla oblongata and pons. Lesions of the brain 
stem were located in the main sensory and spinal tract nuclei of the 
trigeminal nerve, and led the authors to suggest that generalization of 
infection to the central nervous system (CNS) was accomplished by 
neural spread. 
Further evidence for neural spread of virus to the CNS following 
intranasal infection was provided by Bagust and Clark (4). Virus was 
recovered only from the nasal mucosa and tonsils of calves killed 2 days 
post inoculation, but was present in the mandibular and maxillary branches 
of the trigeminal nerve and the trigeminal ganglia of calves killed 4 
and 5 days post-inoculation. Hall et âl. (34) and Edington et al. (28) also 
have described CNS infection in cattle following intranasal inoculation 
of BHV-1. 
Following conjunctival inoculation of virus, histopathologic lesions 
were detected in the conjunctiva, trigeminal ganglia, and medulla oblongata. 
The location of the lesions in the brain stem was consistent with neural 
spread of infection via the trigeminal and lacrimal nerves (77). 
Vaginal infection of cattle with BHV-1, like nasal infection, 
resulted in wide spread generalization of infection. Davies and Duncan 
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(22) isolated virus from tissues of the genital tract, sacral spinal cord, 
and conjunctiva of calves killed 4 days post-infection. In addition, 
BHV-1 was detected in the sacral and cervical spinal cord, trigeminal 
ganglia, medulla, pons, cerebrum, spleen, adrenal gland, and nasal 
mucosa from animals killed 9 and 11 days post-infection. Although virus 
was isolated from neural tissue, these authors failed to find histo­
pathologic evidence of neural involvement. In contrast, Narita et al. 
(76) observed early histopathologic lesions in the sacral spinal cord 
and sacro-lumbar spinal ganglia of vaginally Inoculated cows, with later 
appearing lesions being detected in the trigeminal ganglion, medulla 
oblongata, and cerebrum. In addition, BHV-1 specific fluorescence was 
detected in satellite cells of the trigeminal ganglion from a calf killed 
12 days post infection. These authors suggested that early and late 
neural Infection resulted from centripetal spread of virus along sensory 
nerve fibers of the vagina and nasal mucosa respectively. This inter­
pretation was consistent with the virus isolation data of Davies and 
Duncan (22). 
Persistent phase of infection 
Attempts have been made to determine what tissues, and more specif­
ically, what cell types harbor BHV-1 between the acute infection and 
subsequent recurrent infections. McKercher et al. (65), using tissue 
homogenates for virus isolation, were unable to isolate BHV-1 from res­
piratory tissues, ocular tissues, the CNS, and the circulatory system 
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of cattle killed 24 to 290 days post-infection. Bagust and Clark (4) 
and Edington et al. (28) also were unable to isolate virus from the CNS 
of calves killed 28 days post-infection. Narita et al. (75) failed to 
isolate virus or detect virus specific fluorescence in the nasal mucosa, 
trigeminal ganglia, medulla oblongata, and cerebrum of intranasally infected 
calves killed 30 to 98 days post-infection. Sheffy and Davies (105) 
using expiant culture for virus isolation, failed to recover BHV-1 from 
the upper respiratory tract, lower respiratory tract, trigeminal ganglia, 
medulla oblongata, cerebrum, adrenal gland, and reproductive tract of 
non-dexamethasone treated persistently infected animals. Similar results 
using expiant culture for virus isolation have been obtained by others 
(21,22). 
Using an expiant culture procedure, Homan and Easterday (40) recently 
have isolated BHV-1 from the trigeminal ganglia of clinically normal 
cattle. Virus was isolated 7-24 days after expiant culture initiation 
from 10% of the ganglia examined. In addition, these authors have 
demonstrated the presence of BHV-1 DNA in neurons of the trigeminal and 
superior cervical ganglia of persistently infected calves (41). 
Pathologic changes and BHV-1 specific fluorescence have not been 
observed in tissues taken from persistently infected cattle (22,75,78,79). 
Recurrent phase of infection 
The pathogenesis of recurrent BHV-1 infection has been studied 
following dexamethasone treatment of persistently infected cattle. 
Davies and Duncan (22) have described recurrent BHV-1 infection in 
14 
cattle Initially infected by the nasal route. Histopathologic evidence 
of recurrent infection was confined to the initial site of inoculation 
and the trigeminal ganglia. However, virus was isolated from the medulla 
and from vaginal swabs taken during the recurrent infection. Narita 
et al. (78) observed BHV-1 specific fluorescent neurons In the trigeminal 
ganglia of calves, initially infected by the nasal route, 3 days after 
dexamethasone treatment initiation, but were unable to isolate virus 
from them. The appearance of fluorescent cells in the ganglion 1-2 days 
before the appearance of virus in the nasal secretions led the authors to 
suggest that the trigeminal ganglion was the site of virus persistence. 
Unlike the results of Davies and Duncan (22), Narita et al. (78) found 
histopathologic evidence of CNS involvement during recurrent BHV-1 
infection. Lesions were observed in the medulla oblongata 4 days post-
dexamethasone treatment initiation, and were detected in the pons and 
cerebrum of treated calves 7 days post-treatment initiation. Lesions of 
the brain stem were confined to the main sensory and spinal tract nuclei 
of the trigeminal nerve, which suggested virus spread from the ganglia 
to the brain following dexamethasone treatment. 
Recurrent BHV-1 infection in cows initially infected by the vaginal 
route involved the site of inoculation, the upper respiratory tract, and 
the nervous system. Davies and Duncan (22) found that histopathologic 
lesions were confined to the vagina, although virus was isolated from 
the upper respiratory tract, trigeminal ganglia, medulla, and the cervical 
and sacral spinal cord. Narita et al. (79) first recovered BHV-1 from 
vaginal secretions 3 days post-dexamethasone treatment initiation. 
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Pathologie changes were observed in the lumbosacral spinal cord and the 
associated sensory ganglia 4 days post-treatment initiation, although 
virus was not recovered from these tissues. Virus-specific fluorescence 
was detected in satellite cells of the sacrospinal ganglia 4 days post-
treatment initiation, and in Schwann cells of the sensory nerve fibers 
of the vagina at 6 days post-treatment. The authors concluded that the 
sacrospinal cord and ganglia were likely sites of BHV-1 persistence in 
vaginally infected animals. 
Persistent Infection with Herpes Simplex Virus 
The herpesviruses have been divided into three subfamilies, one of 
which is the alpha herpesvirus group. This group is made up of herpes­
viruses that exhibit the following common characteristics: (1) a genome 
of double stranded DNA from 85-110 x 10^ daltons with sequences from both 
or either terminus present in an inverted form internally; (2) a repli-
cative cycle of less than 24 hours; (3) a variable host range; (4) a virus 
highly cytopathic in cell culture; and (5) an ability to establish persistent 
infection in nervous tissue (62). 
Persistent infection with herpes simplex virus (HSV) has been 
extensively studied, and is better understood than the persistent infections 
established by any other viruses in the alpha herpesvirus group. This 
understanding is due to the growing amount of information on the molecular 
biology of the virus itself and the availability of convenient laboratory 
animal models of persistent infection. 
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Bovine herpesvirus-1 (BHV-1) is a putative member of the alpha 
herpesvirus group and shares many common properties with HSV (105). These 
similarities warrant the inclusion of a review on persistent infection 
with HSV. 
Herpes simplex virus has been shown to be responsible for a variety 
of disease conditions in man. Included among these are urogenital 
infections, gingivostomatitis, keratitis, conjunctivitis, cheilitis, 
meningoencephalitis, and systemic infection (5,72). Persistent infection 
is thought to occur in most, if not all persons following primary infection 
with HSV (72). Clinically apparent incidents of recurrent herpetic 
disease are estimated to occur in 20-40% of the population (108). 
Asymptomatic recurrent infections also have been described (1,12,96). 
The pathogenesis of persistent HSV infection in humans, although not 
directly studied, is inferred from a variety of clinical and experimental 
observations. Clinical observations initially suggested that the sensory 
nerves or ganglia were involved in the pathogenesis of persistent HSV 
Infection (5,14,15,47). In addition, virus was isolated from sensory 
and autonomic nerve ganglia of clinically normal individuals (7,23,31, 
58,71,123,124). These two observations, along with extensive corroborative 
evidence from animal models of persistent HSV infection (19,27,47,86,109), 
have led to the following generally accepted scheme for the pathogenesis 
of recurrent HSV infection in humans. Following acute virus infection 
HSV is transported centripetally via nerves to local nerve ganglia. The 
virus persists in the ganglia in an as yet unknown state between periods 
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of recurrent Infection. During the persistent phase of the Infection 
virus can not be recovered from ganglionic tissue homogenates, but can be 
isolated from expiant cultures. Following an inducing stimulus, virus is 
reactivated and transported centrlfugally via nerves to the Initial site 
of Infection where virus shed with or without the appearance of clinical 
disease occurs. 
Animal models of persistent HSV infection 
The mouse model Among the laboratory animal models of persistent 
HSV infection, the mouse model has been the most extensively studied. 
The acute infection observed in mice following inoculation with HSV-1 
and HSV-2 has been characterized using virus isolation, hlstopathology, 
fluorescent and enzyme-linked antibody staining and electron microscopy. 
Generalization of HSV Infection was shown to occur following virus 
replication at the site of inoculation (16,26,36,50,51,55,97). Neural 
spread of HSV has been considered to be the primary mechanism for the 
generalization of infection to the central nervous system. Cook and 
Stevens (16) detected the sequential appearance of HSV-1 in the sciatic 
nerve, sarcosciatic spinal ganglia, spinal cord, and brain of mice 
following foot pad inoculation of virus. Lascano and Berria (55), using 
an enzyme-linked antibody staining procedure, also have demonstrated this 
sequence of virus spread in mice inoculated by the footpad route. 
Kristensson et al. (50,51) showed that HSV infection was detected first 
in the trigeminal ganglion and later in the brain stem of animals 
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inoculated via the corneal route. The location of the brain stem lesions 
suggested that HSV infection of the central nervous system resulted from 
neural spread of virus. Price and Schmitz (91) observed that post­
ganglionic neurectomy carried out before intraocular infection with 
HSV-1 totally eliminated the spread of virus to the superior cervical 
ganglion. 
Although neural spread of HSV has been generally accepted as the 
primary means for the spread of virus to the central nervous system, the 
exact mechanism responsible for neural spread has remained quite con­
troversial. Retrograde axonal transport of virus was suggested as one 
possible mechanism for neural spread. Kristensson et al. (50) found that 
horseradish peroxidase, a protein tracer known to be transported by 
retrograde axonal transport, was transported from the site of viral 
inoculation to neurons of the sensory ganglion corresponding to those 
infected with HSV. In addition, Hill et al. (36), Cook and Stevens (16) 
and Yamamoto et al. (127) observed, using electron microscopy, viral 
particles in axons near neuronal perikarya, but failed to observe them 
distal to that area. A variety of indirect observations also were 
advanced as evidence supporting axonal transport of virus. Cook and 
Stevens (16) argued that axonal spread would account for: 1) the rapid 
appearance of virus in the ganglion; 2) the observation that neurons are 
infected first, with infection then spreading to other ganglion cell 
types; and 3) the observation that infection progresses even in the 
presence of high levels of neutralizing antibody. 
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Others have suggested that neural spread is best explained by cell 
to cell transmission along nerve fibers or by the passive motion of 
virions along the intercellular space of the nerve fiber. Lascano and 
Berria (55) found extensive replication of HSV in Schwann cells of the 
sciatic nerve, while failing to detect any viral particles within axons. 
They concluded that cell to cell spread of infection was consistent with 
their observations. In contrast, Dillard et al. (26) and Cook and Stevens 
(16) observed that Schwann cells associated with peripheral nerves 
replicated HSV poorly, if at all. 
Factors extrinsic and intrinsic to nerve ganglia have modified the 
course of acute HSV ganglionic infection in mice. Tenser and Dunstan 
(116) found that thymidine kinase-deficient mutants of HSV showed impaired 
replication in ganglionic neurons, even though virus titers observed 
in ocular tissues were similar to those seen with wild type virus. Price 
and Schmitz (91) observed that postganglionic neurectomy, performed after 
virus had reached the superior cervical ganglion, augmented the acute 
phase of the infection. Intraganglionic viral replication also was 
prolonged by using athymic nude mice or immunosuppressed conventional 
mice (87,91). 
Persistent HSV infection was established in almost all mice that 
survived the acute infection (17,61,110,119). Following the acute phase 
of infection, latent virus was isolated, using expiant procedures, from the 
dorsal root ganglia, autonomic ganglia, spinal cord, brain stem, and 
adrenal gland of persistently infected mice (17,48,64,92,110,119). 
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Cook and Stevens (17) have shown, following Intravenous inoculation of 
virus, that 83% and 25% of the mice harbored latent HSV-1 in the dorsal 
root ganglia and central nervous system respectively. Tobin et al. 
(119) observed that 80% of the mice harbored latent virus in the pelvic 
sensory ganglia following cervicovaginal inoculation with HSV-2. Unlike 
other reports. Hill et al. (39) recently isolated HSV from the skin of 
clinically normal persistently infected mice, and suggested that the 
skin also may be a site of viral latency. 
Herpes simplex virus DNA has been detected in the trigeminal ganglion 
and brain of persistently infected mice (13,93,104). Puga et al. (93) 
found that HSV DNA was present in the trigeminal ganglion at a level of 
0.1 genome equivalents per cell during the persistent phase of the 
infection. Cabera et al. (13) reported that 30% of the brains from 
persistently infected animals contained HSV DNA sequences, although 
latent virus was isolated from only 5%. 
Spontaneous incidents of recurrent herpetic disease in persistently 
infected mice were observed by Hill et al. (37). Recurrence of infection 
was detected in approximately 50% of the persistently infected animals 
monitered over a 150 day period, and was characterized by erythema of the 
original virus inoculation site. Virus isolation and electron microscopic 
procedures demonstrated the presence of HSV in biopsies taken from the 
lesions. 
A variety of experimental treatments has been used on mice in an 
attempt to induce the reactivation of latent HSV. However, the mechanisms 
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of action of these reactivation-inducing stimuli are not understood. 
Stevens et al. (113) demonstrated that severe pneumococcal pneumonia 
in persistently infected mice lead to reactivation of latent HSV. Virus 
was recovered from the spinal ganglia and sciatic nerve of treated mice, 
but recurrent disease was not observed. Price and Schmitz (90) -and 
Waltz et al. (122) found that postganglionic neurectomy induced HSV 
reactivation in associated ganglia. Preganglionic neurectomy failed to 
induce viral reactivation in the superior cervical ganglia of persistently 
infected mice (90). 
Trauma to the original site of virus inoculation has proven 
successful in inducing viral reactivation and recurrent viral disease 
(10,11,38,43,103). Hill et al. (38) found that mild trauma, which 
consisted of stripping the originally infected ear with cellophane tape, 
resulted in recurrent lesions in 30% of the persistently infected mice 
2-5 days post-treatment. Herpes simplex virus was isolated from the 
recurrent lesions. Hurd and Robinson (43) have shown that 47-85% of 
persistently infected mice developed recurrent lesions following epilation 
of the hair over the original infection site. Sekizawa et al. (103) 
observed an increase in the levels of HSV neutralizing antibodies in 
90% of the persistently infected mice following dry ice treatment of 
the original inoculation site. This result was not observed if the 
animals were treated at a site different from the original inoculation 
site. The rises in serum neutralizing antibody were considered as 
evidence of viral reactivation. 
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Attempts to reactivate latent HSV or induce recurrent disease 
using immunosuppressive drugs have met with varying degrees of success. 
Prednisolone treatment, but not hydrocortisone treatment induced the 
recurrence of disease in 17% of the persistently infected animals 
12-30 days post-treatment (212). Openshaw et al. (87) found that 
cyclophosphamide treatment resulted in the reactivation of latent HSV 
in the trigeminal ganglia of 70% of the treated animals. In addition, 
Kurata et al. (53) observed recurrent lip lesions and HSV specific 
fluorescence in the trigeminal ganglia of persistently infected mice 
treated with cyclophosphamide. Others have failed to obtain these 
results following cyclophosphamide treatment of persistently infected 
mice. Price and Schmitz (90) reported that cyclophosphamide was not 
effective in reactivating latent HSV in superior cervical ganglia. Blyth 
et al. (10,11) found that cyclophosphamide treatment failed to increase 
the incidence of recurrent clinical disease in persistently infected 
mice. 
The rabbit model Rabbits have proven to be an excellent 
laboratory model for the study of acute and persistent HSV infection. 
Keratitis (68,69,94), uveitis (69), conjunctivitis (69), and encephalitis 
(73,74,120) were produced in rabbits following experimental inoculation 
of HSV-1. Following corneal inoculation, virus or virus-specific 
fluorescence was detected in the corneal epithelium, the trigeminal 
ganglia, and the brain stem (6,94,112). Pathologic evidence has suggested 
that generalization of virus from ocular tissues to the brain occurs by 
intra-axonal spread of virus (6,120). However, reports have shown that 
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non-axonal cell to cell spread of virus along nerve fibers also 
occurs (73,74). 
Persistent infection with HSV-1 has been shown to occur in rabbits 
following corneal inoculation. Nesbum et al. (83) recovered latent 
HSV, using an expiant procedure, from 73% of the trigeminal ganglia 
examined, but failed to recover virus from the conjunctiva, cornea, iris, 
nictitating membrane, lacrimal gland, trigeminal nerve, and brain stem 
of persistently infected rabbits. Stevens et al. (112) also recovered 
latent virus from 5 of 6 trigeminal ganglia taken from rabbits 4 to 8 
months post-inoculation. Similar results have been reported by others 
(6,94,95). Unlike other reports, Knotts et al. (48) recovered HSV-1 
from 5 of 14 brainstems taken from persistently infected rabbits 1-12 
months post-inoculation. 
Spontaneous reactivation and shed of HSV-1 from persistently 
infected rabbits have been observed. Nesburn et al. (82) observed 
spontaneous reactivation in 13 of 20 previously infected rabbits' eyes. 
Reactivation often was accompanied by clinically evident disease, 
although reactivations without evidence of disease also were seen. 
Stevens et al. (112) and Nesburn et al. (83) have reported similar 
findings with respect to spontaneous reactivation and shed of HSV-1. 
Attempts have been made to induce reactivation and shed of HSV-1 
from persistently infected rabbits. Laibson and Kibrick (54) found that 
epinephrine induced reactivation and shed of HSV-1 in some treated 
animals. Viral reactivation often was accompanied by clinically apparent 
disease. Nesburn et al. (84) demonstrated that mechanical stimulation 
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of latently infected trigeminal ganglia resulted in predictable reacti­
vation and shed of HSV-1. Virus was detected in ocular swabs as early as 
18 hours post-treatment and was seen in 80% of the animals by 48 hours 
post-treatment. 
The guinea pig model Persistent HSV infections were established 
in guinea pigs following an acute footpad (30,100), vaginal (3,101), 
or corneal Infection (117). Virus was isolated from the site of 
inoculation and the nervous system of acutely infected guinea pigs. 
Scriba (100) isolated HSV-2 from the footpad, sciatic nerve, and the 
dorsal root ganglia of guinea pigs during acute footpad infection. 
Following vaginal inoculation of guinea pigs with HSV-2, virus was detected 
in the lumbosacral dorsal root ganglia, lumbosacral spinal cord, genital 
nerves, and the sciatic nerve (101). Tenser and Hsiung (117) found 
HSV-1 in the trigeminal ganglia, brainstem and cerebrum of adult guinea 
pigs following corneal inoculation of virus. 
Spontaneous reactivations of latent HSV with the appearance of 
recurrent foot pad lesions have been described in persistently infected 
guinea pigs. Scriba (100) found that 11 of 13 guinea pigs exhibited 
from 1-7 exacerbations of recurrent disease during a 200 day observation 
period. Recurrent lesions developed at the site of initial infection 
and persisted for 2 to 28 days. During periods of recurrent disease 
virus was isolated from the footpad, sciatic nerve, and the lumbosacral 
dorsal root ganglia. 
In the guinea pig model, latent virus has been recovered, using 
expiant culture, from neural and non-neural tissues. Latent HSV-2 was 
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isolated from the footpad, sciatic nerve, and the lumbosacral dorsal 
root ganglia of animals initially infected in the footpad (102). However, 
latent virus was detected only in the footpad of animals initially 
infected with HSV-1. Following an initial vaginal infection with HSV-2, 
latent virus was isolated from the lumbosacral dorsal root ganglia, 
lumbosacral spinal cord, genital nerves, sciatic nerve, uterus, vagina, 
footpad, and adrenal gland (101). Tenser and Hsiung (117) observed 
that the age of the animal at the time of initial HSV-1 infection had 
an effect on where latent virus was found. Latent HSV-1 was Isolated 
only from the trigeminal ganglia of persistently infected adult guinea 
pigs killed 21-70 days after corneal inoculation of virus, but was 
detected in the trigeminal ganglion, trigeminal root, and brain stem 
of animals that were Initially infected as neonates. 
Neonatal guinea pigs were found to be more likely to develop 
persistent HSV-1 infections than adult animals (117). However, treatment 
of adult guinea pigs with hydrocortisone prior to inoculation of HSV-1 
increased the rate of persistent infection in adult animals. 
Characterization of Persistent HSV Infection In Nerve Ganglia 
Cellular location of persistent virus 
A great deal of evidence has suggested that neurons harbor latent 
HSV. Cook et al. (18) have provided the following evidence in support 
of the neuron: 1) HSV specific fluorescence was detected first in neurons 
of reactivating ganglia; 2) virus specific ultrastructural changes were 
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observed first in neurons of reactivating ganglia and later in surrounding 
cells; and 3) HSV DNA was detected initially in neurons. In addition, 
Baringer and Swoveland (6) and McDougall et al. (63) have made indirect 
observations that are consistent with those of Cook et al. (18). 
Recently, McLennan and Darby (66), using temperature sensitive (ts) 
mutants of HSV for animal inoculation and reactivating persistently 
infected ganglia at the non-permissive temperature, removed the possibility 
that changes seen in neurons were secondary to a primary reactivation 
of HSV in another cell type. Viral specific fluorescence was detected 
in abortively reactivated neurons, but not in any other cell type. 
Initiation and maintenance of persistent infection 
The evidence available strongly suggests that HSV persists in neurons. 
The nature of the virus-cell or virus-cell-host interaction ultimately 
responsible for this phenomenon has not been determined. Two major 
hypotheses have been advanced to explain HSV persistence, although 
definitive evidence supporting or refuting either is still lacking (99, 
109). The "dynamic state" hypothesis proposes that persistent HSV 
infections are chronic infections, with virus continually being produced 
at very low levels in the ganglia. The "static state" hypothesis views 
the neuron-virus interaction as a stable one. In this model, HSV is 
harbored within neurons in a non-replicating state. A triggering 
stimulus is required for viral reactivation and productive replication. 
The "static state" model or minor variations of it is consistent with 
experimental observations to date and is generally accepted as a 
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theoretical base for further experimentation (9,47,98,109). 
Viral gene expression is suspected of playing a role in the 
initiation and/or maintenance of the persistent state, although this 
has not been directly demonstrated (61). Temperature sensitive mutants 
of HSV, restrictive at the host body temperature, differed in their 
ability to establish persistent infection in mice (57). This observation 
suggested that latency-negative ts mutants had lesions in genes responsible 
for products crucial to the establishment of latent infection. Gerdes 
et al. (32) observed that the viral DNA phenotype of HSV ts mutants was 
not correlated with the ability to establish persistent infection and 
noted that latency-negative mutants tended to produce more morphologically 
identifiable viral components than latency-positive mutants. Watson et al. 
(125) recently demonstrated, using revertants of latency-negative mutants, 
that one immediate early and one or more later virus gene products were 
necessary for initiation and/or maintenance of the latent state. 
Apart from the studies using ts mutants, attempts have been made to 
demonstrate viral gene activity in persistently infected ganglia. Puga 
et al. (93), using a DNA-RNA reassociation kinetics procedure, were 
unable to detect viral mRNA in nerve ganglia taken from persistently 
infected mice. McDougall et al. (63) detected viral mRNA in neurons 
of human thoracic ganglia with an iji situ hybridization procedure. 
However, it is not known if the mRNA-containing neurons represent truly 
latent cells or cells undergoing spontaneous reactivation. 
Reports that thymidine kinase-negative mutants of HSV were less 
successful at establishing persistent infections than wild type virus 
28 
(29,116,118), suggested a possible role for viral thymidine kinase in 
the initiation and/or the maintenance of the persistent state. Yamamoto 
et al. (126) detected HSV-1 specific thymidine kinase activity in ganglia 
of persistently infected mice up until 60 days post-inoculation. These 
authors concluded that the presence of viral enzymatic activity, weeks 
after virus was no longer recoverable from tissue homogenates, represented 
continual or intermittent expression of the viral genome during the 
persistent phase of the infection. Unlike Yamamoto et al. (126), Fong 
and Scriba (30) failed to detect any HSV-2 thymidine kinase activity in 
footpads or lumbosacral ganglia taken from persistently infected guinea 
pigs. 
It is unknown what role the host's immune response plays in the 
initiation and/or maintenance of persistent HSV infection (56). Stevens 
and Cook (111) found that anti-viral IgG inhibited intraneuronal viral 
DNA and antigen synthesis in explanted reactivating ganglia. However, 
persistent infections have been maintained in mice lacking detectable 
serum neutralizing antibodies (103). 
Reactivation of persistent infection 
Spontaneous and induced reactivations of HSV infection have been 
described in man, mice, rabbits, and guinea pigs (37,83,100,109). 
Trauma, neurectomy, and immunosuppressive drugs all have induced viral 
reactivation, with or without the reappearance of clinical disease 
(15,38,53,87,90,103). Although no direct evidence is available. 
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hypotheses have been advanced to explain the mechanisms of action of 
these reactivation-inducing stimuli. Central to the question of induced 
viral reactivation has been the actual mechanism of viral persistence. 
Proponents of the "static state" theory of HSV persistence have 
suggested that reactivating stimuli act directly or indirectly on 
cells harboring latent virus. Stimuli are thought to induce productive 
viral replication by altering the existing cell-virus interaction (90, 
103). A second hypothesis is favored by those supporting a "dynamic 
state" view of HSV persistence. Under this scheme stimuli do not act 
on persistently infected cells, but rather they alter the local environ­
ment of the skin and/or affect the immune response in a way that allows 
increased viral replication. This amplification of virus titer then 
would allow detection of otherwise undetectable amounts of virus (10, 
38,99). 
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ABSTRACT 
Persistent infection with bovine herpesvirus-1 (BHV-1) was 
established in all rabbits following conjunctival inoculation of virus. 
Spontaneous reactivations of BHV-1 with and without the appearance of 
recurrent ocular lesions were observed in persistently infected rabbits. 
BHV-1 was reactivated predictably and shed from all persistently 
infected rabbits following the administration of dexamethasone. During 
all reactivations, BHV-1 isolation was restricted to the inoculated 
eye. 
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THE RABBIT MODEL 
Bovine herpesvirus-1 (BHV-1) is responsible for a variety of disease 
conditions in cattle. Included among these are respiratory disease, 
conjunctivitis, vulvovaginitis, balanoposthitis, meningoencephalitis, 
and fatal systemic infection (5). Like other members of the herpesvirus 
group, BHV-1 is capable of establishing persistent infections in its natural 
host species (1,4,15). 
Rabbits have been infected experimentally with BHV-1 and suggested 
as possible laboratory models for studying the pathogenesis of BHV-1 
infection (6,8,9). This study was conducted to determine if rabbits could 
be persistently infected with BHV-1 and to evaluate the rabbit as a 
laboratory model for studying persistent BHV-1 infection. 
Adult white rabbits (2.5-5.0 kilograms) were purchased from a local 
commercial source and were housed in individual cages within an animal 
isolation room. The Cooper strain of BHV-1 was supplied by Dr. A. Strating, 
National Veterinary Services Laboratory, Ames, Iowa, and was used at the 
thirteenth passage level. Bovine lung cells were used throughout the 
experiment and were maintained as previously described (13). Ocular and 
nasal swabs were collected and immediately immersed in 2.0 ml. of Eagle's 
minimum essential medium (MEM) containing antibiotics and fungizone 
(100 I.U. penicillin, 100 pg. kanamycin sulfate, 100 pg. streptomycin 
sulfate, and 5 pg fungizone per ml.), and vigorously shaken for 15 seconds 
prior to plating 0.5 ml. onto bovine lung monolayer cell cultures. 
Cultures were observed daily for the presence of cytopathic effect, and 
discarded if negative after 7 days. Viral isolates obtained were identified 
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as BHV-1 using direct immunofluorescence or neutralization with BHV-1 
antiserum (9). 
Rabbits (N=22) were lightly anesthetized (Metaphane, Pitman-Moore, 
Inc., Washington Crossing, N.J.) and inoculated by instilling 1.5 x 10^ 
plaque forming units of BHV-1 (in 0.2 ml. MEM) in the right conjunctival 
sac. Control animals (N=4) were mock-infected with 0.2 ml. MEM in an 
identical manner. 
Four BHV-1 infected rabbits and one non-infected control rabbit were 
swabbed (right eye, left eye, and nose), for 125 consecutive days to 
monitor for spontaneous reactivation and shed of BHV-1. 
At selected dates post-infection (2-7 months), groups of rabbits were 
treated with dexamethasone (Azium, Schering Corporation, Kenilworth, N.J.), 
in an attempt to induce recurrent BHV-1 infection. BHV-1 infected and 
control rabbits were treated with a four day regimen consisting of daily 
intramuscular injections of 4 mg. of dexamethasone. In a similar manner 
a group of rabbits (N=4) received multiple dexamethasone treatments during 
the course of the experiment. 
The acute phase of the infection has been described (9, D. Rock, W. 
Hagemoser, and D. E. Reed, submitted for publication). Virus was isolated 
consistently from the right ocular swabs for 9-15 days post-infection. 
Virus was isolated sporadically from a few animals until 24 days post­
infection. Virus was not recovered from the non-infected left eye of 
BHV-1 infected rabbits or from non-infected control animals during this 
period. Serum from all inoculated rabbits contained BHV-1 neutralizing 
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antibody when examined at 30 days post-infection. 
Spontaneous reactivation and shed of BHV-1 from the right eye was 
observed in 3 of the 4 infected rabbits which were continuously monitored 
(Table 1). Spontaneous reactivation occurred 33 to 104 days post-infection 
and was characterized by virus shedding for 1-2 days and the absence of 
clinically apparent infection. However, ocular lesions were observed 
in one rabbit (418) undergoing spontaneous reactivation. The non-infected 
control animal monitored in a similar manner was virus-free throughout 
the observation period. 
BHV-1 was isolated from the right eye of all 22 of the previously 
infected rabbits within 4 days after initiation of dexamethasone treatment 
(Table 2). Virus was shed for 5-7 days. BHV-1 also was isolated from 
nasal swabs for 1-3 days. Virus was not isolated from the left eye of any 
of the treated rabbits. Untreated BHV-1 infected rabbits and dexamethasone 
treated non-infected control rabbits remained clinically normal and free 
of virus throughout the treatment period. 
The dexamethasone-induced recurrent infection was characterized by 
a mild to moderate conjunctivitis and the presence of small ulcers on the 
outer right eye lid (Figure 1). These conditions developed on the last 
day of dexamethasone treatment and persisted for 6 to 7 days. This 
recurrent ocular lesion was observed in all rabbits undergoing an initial 
reactivation with dexamethasone. 
Over a period of 15 months, multiple reactivations of BHV-1 in the 
same rabbit were obtained using dexamethasone (Table 3). Virus was 
Table 1. Spontaneous reactivation and shed of BHV-1 from persistently infected rabbits 
No. of spontaneous^ Day post-infection No. of days 
Rabbit No. recurrent episodes BHV-1 first reisolated BHV-1 shed Observations 
414 (non-infected 
control) 0 
415 1 33 (right eye) 1 eye clinically 
normal 
416 0 
417 1 86 (right eye) 2 eye clinically 
normal 
418 3 70 (right eye) 
89 (right eye) 
104 (right eye) 
1 
1 
2 
eye clinically 
normal 
eye clinically 
normal 
small ulcer right 
eye lid present 
day 104-108 
^Ocular (right and left) and nasal swabs were collected from rabbits for 125 consecutive 
days post-infection. 
Table 2. Reactivation of BHV-1 in dexamethasone treated rabbits;^ initial reactivation 
No. of animals positive/Total no. of animals 
Months No. of animals/Total no.^ Day post-treatment initiation Recurrent ocular 
post-infection reactivated/treated BHV-1 first reisolated lesions 
2 3/3 
3 3/3 
4 3/3 
5 2/2 
6 4/4 
7 7/7 
22/22 
9/22 12/22 1/22 22/22 
^rior to treatment, one to two weeks of daily attempts to isolate BHV-1 from the right eye, 
left eye, and nose of infected rabbits were unsuccessful, 
^Rabbits were treated with a four day regimen of dexamethasone, consisting of daily 
intramuscular injections of 4 mg. 
Fig. 1. Recurrent ocular lesions in a rabbit persistently infected 
with BHV-1 7 days after the initiation of dexamethasone 
treatment. Ulceration of the outer eyelid (arrows) 
is evident. 
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Table 3. Reactivation of BHV-1 in dexamethasone treated rabbits:^ multiple reactivations 
Months post-infection^ Result of Day post-treatment No. of days Recurrent 
Rabbit No. reactivation reactivation initiation BHV-1 shed ocular 
attempted attempt first reisolated lesions 
216 3 mo. 2 6. + 
6 mo. + 3 ND + 
11 mo. + 3 6 + 
415 4 mo. + 3 5 + 
7 mo. + 2 5 + 
11 mo. + 3 6 + 
15 mo. + 3 ND + 
416 4 mo. + 3 6 + 
7 mo. + 4 3 + 
11 mo. + 4 3 + 
418 4 mo. + 3 4 + 
7 mo. + 4 1 -
11 mo. + 5 3 -
15 mo. 
^Rabbits were treated with a four day regimen of dexamethasone, consisting of daily 
intramuscular Injections of 4 mg. 
Prior to treatment, one to two weeks of daily attempts to isolate BHV-1 from the right eye, 
left eye, and nose of infected rabbits were unsuccessful, 
(+) denotes a positive instance while (-) represents a negative instance. 
'S^ot determined. 
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isolated from the right but not the left eye in each case. Subsequent 
reactivations observed in the rabbits were quite similar to the initial 
reactivations. A decrease in the duration of virus shed was observed 
in rabbits 416 and 418 in the later reactivations. Clinically apparent 
recurrent infection was observed only during the initial reactivation 
of rabbit 418. An attempt to reactivate rabbit 418 at 15 months post­
infection was unsuccessful. Untreated BHV-1 infected rabbits and 
dexamethasone treated non-infected rabbits were included as controls 
for each reactivation attempt. Control rabbits remained clinically 
normal and free of virus throughout each reactivation period. 
The results indicate that BHV-1 established a persistent infection 
in all experimentally infected rabbits. The rabbit model described in 
this report is consistent with the following observations made on cattle 
persistently infected with BHV-1. Persistent BHV-1 infection in cattle 
is characterized by: 1) most, if not all, animals are persistently 
infected after experimental infection (2,14); 2) spontaneous sporadic 
isolation of virus without evidence of clinical disease is seen in 
persistently Infected animals (1,4,15); and 3) virus can be reactivated 
predictably with or without the appearance of clinical disease in 
approximately 100% of the experimentally infected animals treated with 
dexamethasone (2,7,14). 
Studies on BHV-1 pathogenesis in cattle have suggested that 
BHV-1 persists in the trigeminal ganglion after intranasal and 
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intraconjunctlval inoculation of virus and is transported centrlfugally 
via the trigeminal nerve to produce recurrent virus shed and disease 
(3,10,11,12). Lupton, et al. (9) isolated BHV-1 from the trigeminal 
and optic nerves of rabbits during acute conjunctival infection. The 
restriction of virus isolation during reactivation of persistently 
infected rabbits to the ipsilateral inoculated eye (right eye) described 
in this report, along with the isolation of BHV-1 from rabbit trigeminal 
ganglia during the persistent phase of the infection (D. Rock. W. Hagemoser, 
and D. E. Reed; Part II, herein), suggests that the pathogenesis of 
persistent infection in the rabbit is similar to that thought to occur 
in cattle. The similarities discussed above suggest the usefulness of 
the rabbit in the study of persistent BHV-1 infection. 
We wish to thank H. W. Lupton for many helpful discussions. We 
thank J. Wheeler and M. Tymeson for their helpful assistance in this work. 
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SUMMARY 
The pathogenesis of acute and recurrent bovine herpesvirus-l 
(BHV-1) infection in rabbits following conjunctival inoculation was 
studied using virus isolation, fluorescent antibody staining, and 
histopathologic examination. 
Bovine herpesvirus-l produced a moderate to severe conjunctivitis 
following conjunctival inoculation. Infection was confined to ocular 
tissues and the trigeminal ganglion of the inoculated side. General­
ization of infection to the central nervous system was not observed. 
Recurrent virus shed and ocular disease were induced in persistently 
infected rabbits following dexamethasone treatment. Recurrent BHV-1 
infection, like the acute infection, was confined to ocular tissues and 
the trigeminal ganglia. Bovine herpesvirus-l was isolated from the 
trigeminal ganglia of persistently infected rabbits. In addition, virus-
specific fluorescent cells were detected in the trigeminal ganglia of 
dexamethasone treated rabbits prior to the appearance of virus in ocular 
tissues. These observations suggest that BHV-1 persists in the trigeminal 
ganglia of rabbits following conjunctival inoculation. 
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INTRODUCTION 
Bovine herpesvirus-1 (BHV-1) is responsible for a variety of 
disease conditions in cattle. Included among these are rhinotracheitis, 
conjunctivitis, vulvovaginitis, balanoposthitis, meningoencephalitis, 
and fatal systemic infection (Kahrs, 10). Like other members of the 
herpesvirus group, BHV-1 is capable of establishing persistent infections 
in its natural host species (Bitsch, 3; Huck, Millar, and Woods, 8; 
Snowdon, 21). 
Rabbits have been infected experimentally with BHV-1 and suggested 
as possible laboratory models for studying the pathogenesis of BHV-1 
infection (Lupton, Barnes, and Reed, 13; Lutpon and Reed, 12; Kelly, 11). 
Persistent BHV-1 infections have been established in rabbits following 
conjunctival inoculation of virus. In addition, recurrent virus shed 
and disease have been induced in these persistently infected rabbits 
following the administration of dexamethasone (Rock and Reed, 19). 
This study was conducted to: (1) examine the pathogenesis of 
BHV-1 in rabbits following conjunctival inoculation; (2) examine the 
pathogenesis of recurrent BHV-1 infection in persistently infected 
rabbits following treatment with dexamethasone; and (3) evaluate the 
rabbit as a laboratory model for studying persistent BHV-1 infection. 
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MATERIALS AND METHODS 
Cell culture Bovine lung (BLG) and bovine turbinate (BT) cells 
were grown in Eagle's minimum essential medium with Earle's salts (MEM), 
supplemented with 10% gamma-irradiated fetal calf serum (PCS), 0.16% 
sodium bicarbonate, 8 mM N-2-hydroxyethylpiperazine-N'2-ethanesulfonic 
acid (HEPES), and antibiotics (100 I.U. penicillin, 100 Wg streptomycin 
sulfate, and 100 yg kanamycin sulfate per ml). Cells were grown and 
maintained at 37 C in a humidified air atmosphere containing 5% carbon 
dioxide (COg). 
Virus The Cooper strain of BHV-1 was supplied by Dr. A. Strating, 
National Veterinary Services Laboratory, Ames, Iowa, and was used at 
the thirteenth passage level. Stock virus was maintained at -70 C until 
used. 
Experimental animals and inoculations Adult white rabbits 
2.5-5.0 kilograms) of either sex were purchased from a local commercial 
source and were housed in individual cages within an animal isolation 
room. Rabbits were lightly anesthetized (Metaphane, Pitman-Moore Inc., 
Washington Crossing, N.J.) and inoculated by instilling 1.5 x 10^ plaque 
forming units of BHV-1 in 0.2 ml MEM in the right conjunctival sac. 
Control animals were mock-infected with 0.2 ml MEM in an identical 
manner. Rabbits used in the recurrent infection experiment were inoculated 
in both the right and left conjunctival sac. All rabbits were free of 
serum neutralizing antibodies to BHV-1 prior to inoculation. 
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Experimental design 
Acute infection Rabbits (N=18) were inoculated as described 
above. Three rabbits were killed by electrocution at 2, 5, 8, 11, 14, 
and 25 days post-inoculation (PI). Samples of various tissues were 
collected at necropsy for virus isolation (tissue homogenates), histo-
pathology, and fluorescent antibody staining. 
A group of rabbits (N-«=4) were observed throughout the acute and 
recurrent infection. Ocular and nasal swabs were collected daily during 
the experimental period. 
Recurrent infection Rabbits (N=22) were inoculated bilaterally 
as described above. Based on the isolation of BHV-1 from ocular swabs 
at 5 days PI and the presence of neutralizing antibody at 30 days 
post-infection rabbits were presumed to be persistently infected (Rock 
and Reed, 1980). At selected dates PI (6-8 months), rabbits were treated 
with all or some portion of a four day regimen consisting of daily 
intramuscular injections of 4 mg of dexamethasone (Azium, Schering Corp., 
Kenilworth, N.J.). Rabbits (N=3) were killed by electrocution at 1, 
2, 3, and 6 days post-treatment initiation. Samples of various tissues 
were collected at necropsy for virus isolation (tissue homogenates and 
expiant culture), histopathology, and fluorescent antibody staining. 
Non-treated rabbits (N=10) were killed 4-15 months PI and were handled 
in an identical manner. Prior to dexamethasone treatment (treated animals), 
or necropsy (non-treated animals), one to two weeks of daily attempts 
to isolate BHV-1 from ocular and nasal swabs were unsuccessful. 
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Virus isolation procedures Ocular and nasal swabs were immersed 
in 2 ml of MEM containing antibiotics and fungizone (100 I.U. penicillin, 
100 Vg kanamycin sulfate, 100 yg streptomycin sulfate, and 5 pg fungizone 
per ml) and vigorously shaken for 15 seconds prior to plating 0.5 ml 
on BLU or BT monolayer cell cultures. The remaining sample was stored 
frozen at -70 C until titrated. Titrations of swab samples were 
performed by plaque assay as previously described (Lupton et al., 13). 
Tissue samples for virus isolation were processed immediately. 
Tissue suspensions (10% in MEM) were prepared by homogenization with 
Ten Broeck tissue grinders. Infectivity was titrated by plaque assay. 
Tissue samples for expiant culture were washed in MEM, cut into 
1-5 mm pieces, and cultured in MEM supplemented with 10% PCS, 5% lamb 
serum, antibiotics, and fungizone. Cultures were maintained at 37 C 
in a humidified air atmosphere containing 5% CO^ for 30 to 45 days, with 
medium changes every fifth day. Samples of culture fluid were tested 
for infectivity on BLU or BT monolayers at 5 day intervals. Monolayer 
cultures were observed daily for the presence of cytopathic effect and 
were discarded if negative after 7 days. Randomly selected isolates 
from each animal were identified as BHV-1 using direct immunofluorescence 
or neutralization with BHV-1 antiserum. 
Histopathology and immunofluorescence procedures Tissue samples 
for histopathology were fixed in 10% neutral buffered formalin and 
processed for examination using standard paraffin procedures. Sections 
were stained with hematoxylin and eosin. 
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Tissue samples for immunofluorescence procedures were frozen in 
liquid nitrogen and stored at -70 C. Sections were cut at 5 y, fixed 
in room temperature acetone for 5 minutes, rinsed for 5 minutes in 
0.1 M phosphate buffered saline (PBS), dipped in distilled water, and 
air dried. Direct fluorescent antibody staining was performed as 
previously described (Reed, Bicknell, Larson, Knudtson, and Kirkbride, 
18). Controls included BHV-1 positive and negative tissue sections as 
well as the use of a pre-immune conjugate. 
In the indirect immunofluorescence procedure, sections were flooded 
with a hyperimmune bovine anti-BHV-1 serum and incubated for 45 minutes 
at 37 C in a moist chamber. Sections received two 5-minute rinses in 
PBS prior to staining for 45 minutes with a commercial conjugate (Cappel 
Laboratories, Cochranville, Pa.) of fluorescein-labelled rabbit anti-
bovine IgG. Sections were rinsed twice in PBS (5 minutes each), once 
in distilled water (5 minutes), and mounted with buffered glycerol 
(pH 8.6). Controls included known BHV-1 positive and negative tissue 
sections. A negative serum control was routinely included. 
Electron microscopy Two rabbits were killed by electrocution 
at 5 days post-inoculation. The trigeminal ganglia were removed immediately 
and fixed with 3.5% gluteraldehyde in a 0.1 M sodium cacodylate buffer 
(pH 7.2) for 6 hours at 4 C. Tissues were postfixed with 1% buffered 
osmium tetroxide, dehydrated with alcohol, and embedded in epon-araldite. 
Thick sections were stained with a methylene blue-azure II and basic 
fuchsin stain (Humphrey and Pittman, 9) to orient blocks for thin 
sectioning. Prior to examination, thin sections were stained with 
uranyl acetate and lead citrate. 
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RESULTS 
Acute Infection All rabbits developed conjunctivitis in the 
right eye within 48 hours of inoculation. The ocular lesions were most 
severe 3 to 5 days PI, and were characterized by hyperemia and edema 
of the conjunctiva, injected scleral vessels, and a serous, or in many 
cases, a mucopurulent discharge (Fig. 1). A decrease in the severity 
of the inflammatory response was evident at 6 to 8 days PI. At this 
time, multiple ulcers were observed on the outer right eyelid of most 
rabbits (Fig. 2). By 12 days PI, the inoculated right eyes were normal 
in appearance (Fig. 3). The left eyes of BHV-1 inoculated rabbits and 
the eyes of mock-infected control rabbits remained clinically normal. 
Serum from all 4 of the infected rabbits contained BHV-1 neutral­
izing antibody when examined at 30 days PI. Serum neutralizing titers 
ranged from 8 to 32. 
Virus isolation Bovine herpesvirus-1 was present in swabs 
taken from the right eye of all inoculated rabbits on day 1 PI and could 
be detected for 9-15 consecutive days (Fig. 4). During this period, 
virus also was isolated from nasal swabs, although with less regularity. 
Virus was isolated sporadically from a few animals until 24 days PI. 
Swabs taken from the left eye of inoculated rabbits and from the eyes 
of mock-infected controls were never found to contain virus. 
Figure 1. BHV-1 induced conjunctivitis in a rabbit 4 days after 
conjunctival inoculation. The rabbit had hyperemia of 
the conjunctiva, and a mucopurulent discharge. 
Figure 2. A rabbit 8 days after conjunctival inoculation of BHV-1. 
Note the focal ulceration of the outer eyelid (arrows). 
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Figure 3. A rabbit 14 days after conjunctival inoculation of 
BHV-1. The eye is normal in appearance. 
Figure 4. The mean and 
from rabbits 
sac with 1.5 
range of BHV-1 titers in right ocular swabs 
(N=4) inoculated in the right conjunctival 
X 10^ PFU of BHV-1. 
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The isolation of BHV-1 was confined to ocular tissues of the 
inoculated eye and the nasal mucosa (Table 1). Virus titers were the 
highest in the conjunctiva and cornea, and declined after 5 and 11 days 
PI respectively. No virus was recovered from tissues examined at 25 days 
PI. Virus was not recovered from the trigeminal ganglia, pons-medulla, 
cerebrum, and olfactory bulb using homogenized tissue samples. ' Using 
expiant culture as a virus isolation procedure, BHV-1 was recovered from 
the right trigeminal ganglion in 2 of 4 rabbits killed at 5 days PI, 
but was not recovered from the central nervous system. 
Virus was not detected in the medial retropharyngeal lymph node 
(right and left), adrenal gland, lung, liver, and spleen. 
Immunofluorescence and histopathologic examination Bovine 
herpesvirus-1 specific fluorescence was observed in the right conjunctiva 
and cornea up to 5 days PI (Table 1). Corneal fluorescence was charac­
terized by focal involvement of the corneal epithelium. In these foci 
fluorescence appeared to involve the entire epithelial layer (Fig. 5). 
Focal areas of epithelial fluorescence also were observed in conjunctival 
sections (Fig. 6). Occasionally, fluorescent cells were seen beneath 
the surface epithelium in the sub-mucosa. 
Specific fluorescence was not observed in the right trigeminal 
ganglion of animals killed at 2 days PI, but was present in nine of 
twelve ganglia examined from rabbits killed 5, 8, 11, and 14 days PI. 
Direct and indirect fluorescence procedures failed to detect evidence 
of BHV-1 in the ganglia of rabbits killed at 25 days PI. Homogenous 
Table 1. Distribution of BHV-1 and virus specific fluorescence in 
tissues of rabbits following inoculation into the right 
conjunctival sac® 
Days post--inoculation 
2 5 
Rabbit Number 1 2 3 4 5 6 
Conjunctiva Right 3^5 5^4 1*3 3*6 2?3 
Left 
Cornea Right 3.8 & 3.3 4.6 & 
Left - - - - - -
Ventral lacrimal 
gland Right — 1.8 2.6 — 4*0 -
Left - - - - - -
Harderian gland 
Right 2.5 2.0 2.7 — — -
Left - - - - - -
Trigeminal ganglion 
Right — - -
* * * 
Left - - - - - -
Nasal mucosa 2.2 - 2.3 - - -
Ocular swab Right 4.9^ 3.7 5.1 3.0 3.5 2.9 
Left - - - - - -
Nasal swab 2.3 2.2 3.8 1.8 - -
^irus isolation was attempted using tissue homogenates. 
^Log^g plaque forming units of BHV-1 per gram of tissue. 
(-) indicates a negative sample. 
Swab values are given as Log._ plaque forming units of BHV-1 
per swab. 
* 
Indicates BHV-1 specific fluorescence, negative tissues are 
unmarked. 
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Figure 5. Fluorescence microscopy of a section of the right cornea 
from a rabbit 5 days after conjunctival Inoculation of 
BHV-1. Focal involvement of the entire epithelium is 
visible. X456. 
Figure 6. A focus of BHV-1 specific fluorescence in the epithelial 
layer of the right conjunctiva is evident in a rabbit 
killed 2 days after conjunctival inoculation of virus. 
Fluorescence micrograph X189. 
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nuclear and granular cytoplasmic fluorescence was seen in involved 
neurons (Fig. 7). Fluorescence also was observed in satellite cells 
and small unidentified cells (Fig. 8). Ganglia contained few fluorescent 
cells and often only one positive cell was seen in a tissue section. 
No BHV-1 specific fluorescence was observed in the left trigeminal 
ganglion, pons-medulla, cerebrum, olfactory bulb, medial retropharyngeal 
lymph node and adrenal gland of inoculated rabbits. 
Pathologic changes in the right conjunctiva of animals killed at 
2 days PI consisted of focal ulceration of the surface epithelium with 
a moderate to marked infiltration of heterophils into the base of the 
ulcers, surface epithelium, and sub-epithelial tissues. A moderate to 
marked mononuclear cell infiltration of the underlying mucosa also was 
noted. A decrease in the severity of these lesions was evident by 
day 5 PI. Mild mononuclear cell infiltration of the sub-mucosa was 
observed in several animals at 5 days PI or later. In most rabbits 
examined, mild, diffuse infiltration of heterophils into the surface 
epithelium was observed in both the inoculated and uninoculated conjunctiva. 
Microscopic lesions of the right cornea consisted of focal hetero-
phile infiltration of the epithelium in the area of the limbus. Moderate 
to marked mononuclear cell infiltration of the sub-epithelium and limbic 
stroma was observed below areas of surface inflammation. Moderate 
vascularization and edema were present locally (Fig. 9). These pathologic 
changes were most severe at 2 and 5 days PI, and milder at 8, 11, and 
14 days PI. No lesions were present in the left corneas. 
Figure 7. Fluorescence microscopy of a section of the right 
trigeminal ganglion from a rabbit 5 days after 
conjunctival inoculation of BHV-1. Nuclear 
and granular cytoplasmic fluorescence are present in 
a medium sized neuron. X441. 
Figure 8. Fluorescence microscopy of a section of the right 
trigeminal ganglion from a rabbit 5 days after 
inoculation of BHV-1. A single unidentified fluorescent 
cell is visible. X404. 

Figure 9. Microscopic changes in the right cornea of a rabbit 
5 days after conjunctival inoculation of BHV-1. 
A moderate mononuclear cell infiltration of the limbic 
stroma, along with local vascular dilitation and edema 
are visible. H + E stain; X76. 
Figure 10. Focal interstitial mononuclear cell accumulation in the 
right trigeminal ganglion of a rabbit 5 days after 
conjunctival inoculation of BHV-1. H + E; X 477. 
67 
68 
Lesions of the right trigeminal ganglion consisted of focal inter­
stitial mononuclear cell accumulations. Focal neuronal degeneration, 
neuronecrosis, and neuronophagia were evident to some degree in most 
ganglia (Fig. 10). These lesions were not seen at 2 days PI but were 
present in nine of twelve ganglia examined from rabbits killed 5, 8, 11, 
and 14 days PI. Lesions were present in one of three ganglia examined 
from animals killed at 25 days PI. No lesions were present in the left 
trigeminal ganglia. 
No significant lesions were observed in the ventral lacrimal gland 
(right and left), harderian gland (right and left), adrenal gland, 
pons-medulla, cerebrum, olfactory bulb, and nasal mucosa. 
Electron microscopy of the trigeminal ganglion Foci of 
Inflammation were found in thick sections taken from the trigeminal 
ganglia of two rabbits killed at 5 days PI. Blocks were trimmed and 
thin sections were taken from fifteen different areas of Inflammation. 
Thin sections failed to reveal the presence of virions or evidence of 
viral replication. Areas sampled did contain inflammatory cells and 
all constituent ganglion cell types. 
Recurrent infection The dexamethasone-induced recurrent Infection 
was characterized by a mild to moderate conjunctivitis and the presence 
of small ulcers on the outer right eyelid (Fig. 11). These conditions 
developed on the last day of dexamethasone treatment and persisted for 
6 to 7 days. 
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Virus isolation Bovine herpesvirus-1 was present in swabs 
taken from the right eye of all dexamethasone treated persistently in­
fected rabbits within 72 hours after treatment Initiation. Virus was 
shed from the right eye for 4 to 6 days and was isolated sporadically 
over this period from nasal swabs (Fig. 12). Virus was not isolated from 
the uninoculated left eye of treated rabbits. Non-treated persistently 
infected rabbits and dexamethasone treated uninoculated control animals 
remained virus-free throughout the reactivation period. 
Using expiant culture for virus isolation, BHV-1 was recovered from 
the trigeminal ganglion and the ventral lacrimal gland of non-treated 
persistently Infected rabbits (Table 2). Virus was detected first in 
expiant culture fluids 5 to 25 days after culture initiation. Virus 
was isolated from two of six trigeminal ganglia taken from rabbits killed 
at 1 and 2 days post-treatment initiation, but was not recovered from 
any other tissues. Bovine herpesvirus-1 was isolated both from the 
trigeminal ganglia and ocular tissues of rabbits killed at 3 and 6 days 
post-treatment Initiation. Virus was never isolated from the pons-medulla, 
cerebrum, cranial cervical ganglia, nasal mucosa, harderian gland, 
adrenal gland and medial retropharyngeal lymph node of treated and non-
treated persistently infected rabbits or from the trigeminal ganglia of 
uninoculated control rabbits (N=4). 
Immunofluorescence and histopathologic examination Fluor­
escent cells were detected in the trigeminal ganglia of rabbits killed 
2, 3, and 6 days post-treatment initiation (Table 2). Both neurons and 
smaller unidentified cell types were involved. Like in the acute infection, 
Figure 11. Recurrent ocular lesion in a rabbit 7 days after the 
initiation of dexamethasone treatment. Focal ulcerations 
(arrows) of the outer eyelid are evident. 
Figure 12. The mean and range of BHV-1 titers in right ocular swabs 
from rabbits (N=3) treated with dexamethasone. 
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Table 2. Distribution of BHV-1 and virus-specific fluorescence in tissues of persistently infected 
rabbits following dexamethasone treatment^ 
Non-treated Days post treatment initiation 
1 2 3 6 
Isolation^ Fat^ Isolation Fat Isolation Fat Isolation Fat Isolation Fat 
Ocular swab 0/10 0/3 1/3 2/3 3/3 
Conjunctiva 0/10 0/7 0/3 0/3 0/3 0/3 1/3 0/3 2/3 0/3 
Cornea 0/10 0/7 0/3 0/3 0/3 0/3 1/3 1/3 3/3 0/3 
Ventral Lacrimal 
Gland 1/10 0/7 0/3 0/3 0/3 0/3 0/3 0/3 2/3 0/3 
Trigeminal 
Ganglia 5/10 0/7 1/3 0/3 1/3 2/3 2/3 2/3 2/3 2/3 
^Rabbits were used 4-15 months PI. 
^Virus isolation was attempted using expiant cultures (number positive/number examined). 
Swabs were cultured as described. 
^Fluorescent antibody test (number positive/number examined). 
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there were few fluorescent cells. With a single exception (Table 2), 
EH3Z-1 specific fluorescence was not detected in the conjunctiva, 
cornea, ventral lacrimal gland, harderian gland, nasal mucosa, medial 
retropharyngeal lymph node and adrenal gland of dexamethasone treated 
persistently infected rabbits. Bovine herpesvirus-1 specific fluorescence 
was not observed in tissues taken from non-treated persistently infected 
rabbits or from treated rabbits 1 day post-treatment initiation. 
Corneal lesions consisting of a mild mononuclear cell infiltration 
below the limbic epithelium were observed in four of seven corneas from 
non-treated persistently infected rabbits, and in three of twelve corneas 
examined from rabbits killed 1, 2, 3, and 6 days pibst-dexamethasone 
treatment initiation. A more severe lesion was observed in a rabbit 
killed 6 days post-treatment initiation. The lesion consisted of moderate 
focal aggregations of lymphocytes with some heterophils beneath the 
limbic epithelium. Focal ulceration of the corneal epithelium accompanied 
by epithelial cell swelling and degeneration was also noted. Lesions were 
not observed in uninoculated control animals. 
Pathologic changes in the conjunctiva consisted of a mild to marked 
heterophile infiltration of the surface epithelium. In addition, a mild 
to moderate mononuclear cell infiltration of the sub-epithelium was present 
in some animals. These lesions were present in seven of nine conjunctivas 
taken from rabbits killed at 2, 3, and 6 days post-treatment initiation. 
Lesions were most severe at 3 and 6 days post-treatment initiation. 
With a single exception, lesions were not seen in non-treated persist­
ently infected rabbits. A mild, diffuse infiltration of heterophils 
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into the surface epithelium was observed in most uninoculated control 
animals. 
Recurrent lesions of the trigeminal ganglia were similar to those 
observed during the acute infection. Mild to moderate lesions were 
observed in four of seven non-treated persistently Infected animals. 
The corneal lesions described above were not correlated with the presence 
of trigeminal lesions in non-treated rabbits. Lesions were seen in one 
of three ganglia obtained 1 day post-treatment initiation and in eight 
of nine ganglia examined from rabbits killed 2, 3, and 6 days post-
treatment initiation. Lesions were not detected in the trigeminal ganglia 
of uninoculated control animals. 
A lesion of the central nervous system was observed in a non-treated 
persistently infected rabbit. The lesion, located at the level of the 
ponto-medullary junction, consisted of a focal mononuclear cell infil­
tration in the ventral aspect of the fifth nucleus. Moderate pathologic 
changes also were observed in the trigeminal ganglia of this animal. 
Central nervous system lesions were not seen in any other treated or 
non-treated persistently infected rabbits. 
Recurrent lesions of the outer eyelid consisted of multiple, 
ulcerative, necrotic foci with heterophile and macrophage infiltration 
of the ulcer base. Focal hydropic degeneration of epithelial cells also 
was noted (Fig. 13). No significant lesions were observed in the ventral 
lacrimal gland, harderian gland, adrenal gland, and nasal mucosa. 
Figure 13. Focal ulceration of the outer eyelid of a rabbit 
6 days after the initiation of dexamethasone treatment. 
Hydropic degeneration is visible in epithelial cells 
adjacent to the ulcerated areas. H + E; X214. 
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DISCUSSION 
The present report demonstrates that BHV-1 produces a moderate to 
severe conjunctivitis following conjunctival inoculation. The ocular 
infection described here is similar to those reported by others in 
rabbits (Lupton et al., 13; Lupton and Reed, 12; Kelly, 11) and cattle 
(Narita, Inui, Namba, and Shimizu, 16; Davies and Duncan, 5; Abinanti 
and Plumer, 1). 
Acute BHV-1 infection in rabbits differed in several aspects from 
observations made on experimentally infected cattle. In rabbits, BHV-1 
infection was confined to ocular tissues and the trigeminal ganglion 
of the inoculated side. The generalization of infection that occurs 
in cattle following peripheral inoculation of virus (Davies and Duncan, 
5; McKercher, Wada, and Straub, 14) was not seen in rabbits. The neural 
involvement observed in BHV-1 infected rabbits also differed from that 
seen in cattle. In the rabbit, acute infection of the trigeminal ganglion 
was mild. Virus was recovered from acutely infected trigeminal ganglia 
only by using expiant culture for virus isolation. Immunofluorescence 
procedures demonstrated few fluorescent cells in acutely infected 
ganglia, and ultrastructural examination failed to reveal herpes virions 
or evidence of viral replication. In contrast, BHV-1 has been isolated 
from the trigeminal ganglia of intranasally inoculated calves up to 
15 days PI using tissue homogenates (Narita, Inui, Namba, and Shimizu, 
15). Titers of BHV-1 ranging from 10^'^ to 10^'^ TCID^Q per gram of 
ganglion tissue have been reported (Bagust and Clark, 2). 
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Generalization of BHV-1 infection to the central nervous system, a common 
finding in experimentally infected cattle (Narita et al., 16; Narita 
et al., 15; Davies and Duncan, 5; McKercher et al., 14), was not seen 
in rabbits following conjunctival inoculation. 
The results indicate that recurrent virus shed and disease could 
be induced in all BHV-1 persistently infected rabbits following dexa-
methasone treatment. These findings are similar to those previously 
reported in rabbits (Rock and Reed, 1981, Part I, herein; Rock and Reed, 
19) and cattle (Davies and Carmichael, 4; Sheffy and Davies, 20). In 
rabbits, recurrent BHV-1 infection was confined to ocular tissues and 
the trigeminal ganglia. 
Bovine herpesvirus-l was isolated from the trigeminal ganglion in 
five of ten non-treated persistently infected rabbits. With a single 
exception (Table 2), virus was not isolated from any other tissues in 
these animals. In addition, immunofluorescence procedures detected 
BHV-1 specific fluorescent cells in the trigeminal ganglion of dexa-
methasone treated rabbits prior to the appearance of virus or virus 
specific fluorescence in ocular tissues. These findings suggest that 
BHV-1 persists in the trigeminal ganglion of persistently infected rabbits 
and is shed to the periphery following dexamethasone treatment. Centrif­
ugal transport of virus via nerves is suggested by: (1) the rapid 
appearance of virus in ocular tissues following dexamethasone treatment ; 
(2) the restriction of recurrent virus shed and disease to the originally 
inoculated eye (Rock and Reed, 1980); and (3) the isolation of BHV-1 from 
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the trigeminal and optic nerves of rabbits following conjunctival 
inoculation (Lupton et al., 13). 
Sensory and autonomic nerve ganglia have been suggested as sites 
of BHV-1 persistence in infected cattle. Bovine herpesvirus-1 specific 
fluorescence was detected in the trigeminal ganglia of dexamethasone 
treated persistently infected calves prior to the appearance of virus in 
the nasal mucosa (Narita et al., 17). Bovine herpesvirus-1 also has 
been isolated from the trigeminal ganglia of clinically normal cattle at 
slaughter (Homan and Easterday, .6), although prior attempts by other 
researchers to isolate virus from ganglia of non-dexamethasone treated 
experimentally infected cattle were unsuccessful (Davies and Duncan, 5; 
Davies and Carmichael, 4). Recently, Homan and Easterday (7) have 
demonstrated the presence of BHV-1 DNA in neurons of the trigeminal and 
superior cervical ganglia of persistently infected calves. 
Pathologic changes, consistent with those seen in recurrent BHV-1 
infection, were detected in four of seven trigeminal ganglia examined 
from non-treated persistently infected rabbits. Bovine herpesvirus-1 
eventually was isolated from three of the four ganglia, although no virus 
specific fluorescence was detected in any of the ganglia at the time of 
expiant culture. Spontaneous reactivation of BHV-1 has been described 
in persistently infected rabbits (Rock and Reed, 19) and may provide 
an explanation for this observation. 
Unlike observations made on persistently infected cattle following 
dexamethasone treatment (Narita et al., 17; Davies and Duncan, 5), 
evidence suggesting central nervous sytem involvement in recurrent BHV-1 
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infection was not seen in rabbits. However, histopathologic lesions of 
the brain stem, consistent with those seen in BHV-1 infections of cattle 
(Narita et al., 16; Narita et al., 17), were observed in a single 
non-treated persistently infected rabbit. Virus or virus specific 
fluorescence was not detected in the brain stem of this animal. This • 
observation suggests that, although not characteristic, central nervous 
system involvement may occur in adult rabbits under certain conditions. 
Persistent BHV-1 infection in rabbits is characterized by: (1) most, 
if not all, animals are persistently infected following conjunctival 
inoculation (Rock and Reed, 19); (2) spontaneous sporadic isolation of 
virus with or without evidence of clinical disease is seen in persistently 
infected animals (Rock and Reed, 19); and (3) virus can be reactivated 
predictably from experimentally infected animals following dexamethasone 
treatment (Rock and Reed, 19). These observations are consistent with 
those made on BHV-1 infected cattle (Snowdon, 21; Sheffy and Davies, 
20). The similarities described above in conjunction with the similarities 
in pathogenesis described in this report suggest the usefulness of the 
rabbit as a laboratory model for the study of persistent BHV-1 infections 
of cattle. 
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SUMMARY AND CONCLUSIONS 
This study consisted of two parts: (1) an examination of the rabbit 
as a laboratory model for the study of persistent bovine herpesvirus-1 
infection (BHV-1) and (2) an examination of the pathogenesis of acute 
and recurrent BHV-1 infection in rabbits following conjunctival inoculation. 
Persistent Infection with BHV-1 was established in all rabbits 
following conjunctival inoculation of virus. Spontaneous reactivations 
of BHV-1 with and without the appearance of recurrent ocular lesions 
were observed in persistently infected rabbits. BHV-1 was reactivated 
predictably and shed from all persistently infected rabbits following 
the administration of dexamethasone. Recurrent virus shed and ocular 
lesions were restricted to the inoculated eye. 
The pathogenesis of acute and recurrent BHV-1 infection in rabbits 
following conjunctival inoculation was studied using virus isolation* 
fluorescent antibody staining, and histopathologic examination. BHV-1 
produced a moderate to severe conjunctivitis following conjunctival 
inoculation. Infection was confined to ocular tissues and the trigeminal 
ganglion of the inoculated side. Generalization of infection to the 
central nervous system was not observed. 
Recurrent BHV-1 infection, induced following dexamethasone treatment, 
was confined to ocular tissues and the trigeminal ganglia. BHV-1 was 
isolated from the trigeminal ganglia of persistently infected rabbits. 
In addition, virus specific fluorescent cells were detected in the 
trigeminal ganglia of dexamethasone treated rabbits prior to the appearance 
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of virus in ocular tissues. These observations suggest that BHV-1 
persists in the trigeminal ganglia of rabbits following conjunctival 
inoculation. 
In conclusion, the rabbit model of persistent BHV-1 infection 
described in this study faithfully reproduces many aspects of the 
persistent infection observed in cattle, and should prove useful in the 
study of persistent BHV-1 infection. 
A more detailed understanding of this laboratory model, and BHV-1 
persistence in general, would be provided by the following research: 
1. Research is needed to determine what ganglion cell types are. 
infected following conjunctival inoculation of rabbits with 
BHV-1. Attempts ^ should be made to determine if all cell types 
are permissive for viral replication. 
2. Trigeminal ganglia from persistently infected rabbits should 
be examined to determine what cell types harbor latent virus, 
and what state of activity the viral genome is in. Experiments 
utilizing nucleic acid hybridization could be used to answer 
both of these questions. 
3. Further study is needed to elucidate the mechanism of dexa-
methasone induced reactivation of persistently infected animals. 
4. Additional research is needed to determine if the natural course 
of persistent BHV-1 infection can be modulated. More specifi­
cally, can immunologic or physiologic manipulations prevent 
the establishment of persistent infections in non-infected 
animals, or prevent the reactivation and shed of virus in 
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animals already persistently infected? Preliminary studies 
could be conducted easily in rabbits. 
5. The absence of central nervous system involvement in adult 
rabbits during acute or recurrent BHV-1 infection should be 
investigated further. 
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